CIK 0001827090 · Large accelerated filer
Certara, Inc.
Sign in to watch- Ticker
- CERT
- Exchange
- Nasdaq
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (415) 237-8272
- Business address
- 4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −5,264 | $16.76 | $88K | 59,254 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −649 | $17.72 | $12K | 58,605 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −3,024 | $16.75 | $51K | 55,581 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −328 | $17.67 | $6K | 55,253 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −4,740 | $16.77 | $79K | 50,513 |
| 2024-04-02 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale 10b5-1 | −422 | $17.77 | $7K | 50,091 |
| 2024-04-01 | Feehery William F CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +124,779 | 124,779 | ||
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Shares withheld for taxes 10b5-1 | −1,723 | $17.88 | $31K | 167,750 |
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Option exercise 10b5-1 | +6,651 | 174,401 | ||
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Shares withheld for taxes 10b5-1 | −2,245 | $17.88 | $40K | 172,156 |
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Option exercise 10b5-1 | +6,644 | 178,800 | ||
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Shares withheld for taxes 10b5-1 | −2,276 | $17.88 | $41K | 176,524 |
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale 10b5-1 | −3,000 | $18.00 | $54K | 173,524 |
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Option exercise · Restricted Stock Units 10b5-1 | −6,651 | 6,651 | ||
| 2024-04-01 | Traynor Richard M. SVP AND GENERAL COUNSEL | Option exercise · Restricted Stock Units 10b5-1 | −6,644 | 13,288 | ||
| 2024-04-01 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Shares withheld for taxes | −1,532 | $17.88 | $27K | 53,443 |
| 2024-04-01 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Option exercise | +8,646 | 62,089 | ||
| 2024-04-01 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Shares withheld for taxes | −2,733 | $17.88 | $49K | 59,356 |
| 2024-04-01 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Option exercise | +7,852 | 67,208 | ||
| 2024-04-01 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Shares withheld for taxes | −2,690 | $17.88 | $48K | 64,518 |
Page 12 of 29 · 561 trades